Table 5.

Demographic and clinical characteristics of HNSCC patients with low- and high-expression HMMR in protein level (n = 70).

Characters	level	HMMR expression		p
		Low (n = 27)	High (n = 43)
Gender	Female	2 (7.4%)	3 (7.0%)	0.999
	Male	25 (92.6%)	40 (93.0%)
Age	<60 years	15 (55.6%)	17 (39.5%)	0.685
	≥60 years	12 (44.4%)	26 (60.5%)
T classification	T1–T2	13 (48.1%)	17 (39.5%)	0.478
	T3–T4	14 (51.9%)	26 (60.5%)
N classification	N0–1	24 (88.9%)	31 (72.1%)	0.137
	N2–3	3 (11.1%)	12 (27.9%)
Clinical stage	Stage I–II	12 (44.4%)	14 (32.6%)	0.316
	Stage III–IV	15 (55.6%)	29 (67.4%)
Histologic grade	G1	16 (59.3%)	13 (30.2%)	0.055
	G2	6 (22.2%)	15 (34.9%)
	G3	6 (18.5%)	15 (34.9%)
Anatomic site	Oral cavity	8 (29.6%)	7 (16.3%)	0.549
	Oropharynx	1 (3.7%)	3 (7.0%)
	Hypopharynx	1 (3.7%)	3 (7.0%)
	Larynx	17 (63.0%)	30 (67.8%)